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Elective cesarean sectionAbstract Introduction: This study was designed to evaluate the effect of adding dexmedetomidine
to regular mixture of epidural drugs for pregnant women undergoing elective caesarian section with
special emphasis on their sedative properties, ability to improve quality of intraoperative, postop-
erative analgesia and neonatal outcome.
Methods: Fifty women of ASA physical status I or II at term pregnancy were enrolled randomly to
receive either plain bupivacaine plus fentanyl (BF group) or plain bupivacaine plus mixture of fen-
tanyl and dexmedetomidine (DBF group). Incidence of hypotension, bradycardia, Apgar scores,
intraoperative pain assessment, onset of postoperative pain, sedation scores and side effects were
recorded.
Results: No difference in the times taken for block to reach T4 sensory level, to reach the highest
level of sensory block and interval between ﬁrst neuraxial injection and onset of surgery between the
groups. Onset of postoperative pain was signiﬁcantly delayed in the DBF group (P= 0.001), the
need for supplementary fentanyl was signiﬁcantly less in DBF group (P= 0.03), and no signiﬁcant
difference was obtained between both groups regarding neonatal Apgar scores as well as the inci-
dence of hypotension, bradycardia, nausea, vomiting and duration of motor blockade between the
groups. DBF group had signiﬁcantly less incidence of shivering (P= 0.03).
Conclusion: Adding dexmedetomidine to regular mixture of epidural anesthetics in women under-
going elective cesarean section improved intraoperative conditions and quality of postoperative
analgesia without maternal or neonatal signiﬁcant side effects.
ª 2014 Production and hosting by Elsevier B.V. on behalf of Egyptian Society of Anesthesiologists.D license.
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Regional anesthesia is preferred for cesarean section since it
allows a parturient to remain awake and participate in the
birth of her baby while avoiding the risks of general anesthesia
[1]. The combined spinal–epidural (CSE) technique is fre-
quently used to provide anesthesia and analgesia for labor
and delivery [2]. To improve the quality of intraoperative anes-
thesia, postoperative analgesia and aid early ambulation and
recovery of motor block, several agents have been employed
such as opioids and a-2 adrenergic agonist. Some recent pla-
cebo-controlled studies suggest that a-2 adrenergic agonist
has both analgesic and sedative properties when used as an
adjuvant in regional anesthesia [3–11].
Dexmedetomidine is a highly selective a2 adrenergic agonist
with an afﬁnity of eight times greater than clonidine. The dose
equivalence of these drugs had not been studied before, but the
observations of various studies have stated that the dose of clo-
nidine is 1.5–2 times higher than dexmedetomidine when used
in epidural route [12–17]. The anesthetic and the analgesic
requirement get reduced by the use of these two adjuvants
because of their analgesic properties and augmentation of local
anesthetic effects as they cause hyperpolarization of nerve tis-
sues by altering transmembrane potential and ion conductance
at locus coeruleus in the brainstem [18–22]. The stable hemo-
dynamics and the decreased oxygen demand due to enhanced
sympatho-adrenal stability make them very useful pharmaco-
logic agents [23,24].
The safety of the use of dexmedetomidine on neonatal out-
come is a very important issue. Experimental study on acute
exposure of rats to dexmedetomidine at the anticipated deliv-
ery time recorded the absence of any adverse effects on perina-
tal morphology of pups, their birth weight, crown-rump
length, physical growth and postnatal behavioral perfor-
mances and concluded that dexmedetomidine did not affect
those parameters [25].
Others studied the transfer of clonidine and dexmede-
tomidine across the isolated perfused human placenta, and
concluded that dexmedetomidine disappeared faster than
clonidine from the maternal circulation, while even less dex-
medetomidine was transported into the fetal circulation
[26].
Some case reports concluded that dexmedetomidine had no
harmful effects during cesarean delivery [27–29].
Our hypothesis was that the addition of dexmedetomidine
to epidural bupivacaine and fentanyl could improve intraoper-
ative anesthesia and postoperative analgesia in women under-
going elective cesarean section using a CSE technique without
signiﬁcant neonatal side effects.2. Methods
After approval by local research ethics committee, Informed
consent was obtained from all patients participating in the
study. Healthy (ASA I, II), 21–41 year old women at term were
randomly allocated into two groups equally. Computer-gener-
ated simple random sampling procedure was used to allocate
the subjects. Both nulliparous and multiparous women were
included; all were scheduled for elective cesarean section.
Exclusions criteria were twin pregnancy, placenta praevia, opi-oid agonist or agonist/antagonist administration in the preced-
ing 6 h (or within 1 h if given intravenously), obesity
(BMI > 38 kg/m2), extremes of height (<140 or >180 cm),
active labor, history of bleeding diathesis, history or the pres-
ence of cardiac, respiratory, hepatic and/or renal failures or
those who had contraindications to neuraxial block.
The study drugs were prepared in unlabeled syringes by
anesthesia technician not involved in the study who used the
randomization protocol to assign participants to their respec-
tive groups. Patients were premedicated with oral ranitidine
150 mg the night before and on the morning of surgery. The
second dose was given with oral metoclopramide 10 mg. In
the operation theater, a good intravenous access was secured
and monitoring devices were attached such as electrocardio-
graph (ECG), pulse oximetry (SpO2), non-invasive blood pres-
sure (NIBP), and respiratory rate. Baseline parameters were
recorded. A ﬂuid preload of 500 mL of lactated Ringer’s solu-
tion was given and baseline blood pressure and heart rate were
recorded in the right-wedged supine position. Oxygen at 6 L/
min was administered via Hudson face mask.
In the sitting position, CSE anesthesia was performed using
a needle-through-needle technique. The epidural space was
located using loss of resistance to air with an 18-gauge Tuohy
needle. The dural puncture at L3-4 level was achieved with 27-
gauge pencil point needle. After conﬁrmatory aspiration of
cerebrospinal ﬂuid, 2 mL of 0.5% hyperbaric bupivacaine
was injected intrathecally. The spinal needle was withdrawn
and a 20-gauge epidural catheter inserted 3–4 cm into the epi-
dural space. The catheter was secured and the patient placed in
the supine position with left uterine displacement. All then
received 20 mL of study solution via the epidural catheter. This
was either 10 mL 0.25% plain bupivacaine plus fentanyl
100 lg in 10 mL 0.9% sodium chloride (BF group) or 10 mL
0.25% plain bupivacaine plus mixture of fentanyl 100 lg and
dexmedetomidine 1 lg/kg in 10 mL 0.9% sodium chloride
(DBF group). Hypotension, deﬁned as 20% fall in blood pres-
sure from pre-induction levels or a systolic blood pressure
lower than 100 mmHg, was treated immediately by intrave-
nous injection of 5 mg ephedrine. The level of sensory block
was assessed at 2-min intervals for 30 min after epidural injec-
tion using pinprick. The highest level of sensory block (S max)
and time taken to reach S max were recorded. Motor block of
the lower extremities was assessed at 5 min intervals for 30 min
using the modiﬁed Bromage score (BS): BS0; full ﬂexion of
hip, knee and ankle.BS1; impaired hip ﬂexion.BS2; impaired
hip and knee ﬂexion.BS3; unable to ﬂex hip, knee or ankle.
Complete motor block was deﬁned as BS3. Time intervals
from intrathecal injection to readiness for surgery, skin inci-
sion to delivery and uterine incision to delivery were recorded.
Surgery was performed by one of two consultant surgeons of
similar clinical experience, and they were blinded to the alloca-
tion group. Intraoperative and postoperative pain were
assessed by 10-point verbal rating scale (VRS), in which 0 rep-
resented no pain and 10 represented worst possible pain. VRS
was measured every 15 min intraoperative and every 4 h post-
operatively by an anesthesiologist who was unaware of the
patient allocation group. If women complained of pain
(deﬁned as VRS > 4), intravenous fentanyl was given in
50 lg increments. The requirement for supplementary analge-
sia was noted in different groups.
Sedation scores were recorded using ﬁve-point scale
(1 = completely awake, 2 = awake but drowsy, 3 = asleep
Table 1 Patients demographic and clinical characteristics.
DBF No-25 BF No-25 P value
Age (years) 29.8 ± 4.6 28.8 ± 4.9 0.47
Height (cm) 167 ± 4.9 168.5 ± 4.2 0.30
Weight (kg) 74.6 ± 8 75 ± 7.7 0.94
Baseline MBP (mmHg) 74.8 ± 7.9 73.8 ± 6.5 0.63
Heart rate (beats/min) 83.2 ± 7.6 80.7 ± 9 0.30
Duration of surgery (min) 49 ± 8 48 ± 8.5 0.63
ASA I/II 19/6 18/7 0.74
MBP: mean blood pressure, DBF: (dexmedetomidine, bupivacaine
and fentanyl group), BF: (bupivacaine and fentanyl group).
Table 2 Block characteristics.
DBF (No-25) BF (No-25) P value
Block characteristics
Time to reach sensory
block (min)
7.2 ± 1.8 7.6 ± 1.7 0.42
Time to S max (min) 9.1 ± 1.4 9.4 ± 1.7 0.50
Time to ready for surgery (min) 7.6 ± 2.1 8.1 ± 2.1 0.40
Recovery of motor block (min) 126.7 ± 29 115.6 ± 27 0.17
Onset of postoperative
pain (min)
321 ± 19 174 ± 15.7 0.001*
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to tactile stimulus, 5 = asleep and not responsive to any stim-
ulus) [30], Just before the initiation of surgery and thereafter
every 15 min during the surgical procedure. Adverse effects
such as hypotension, nausea, vomiting and shivering were also
recorded. All neonates were evaluated by a pediatrician who
was unaware of group assignment. Apgar scores at 1 and
5 min and umbilical cord pH were recorded. The need for neo-
natal oxygen therapy was noted. Breastfeeding was prohibited
for the ﬁrst 24 h after cesarean delivery. Following surgery,
patients were nursed in the postanesthesia care unit (PACU).
Recovery from motor block was deﬁned as time from injection
of epidural solution to BS0. The onset of postoperative pain
deﬁned as the time from completion of surgery to onset of
VAS > 4 was recorded.
3. Statistical analysis
Data are expressed as mean ± SD or frequency and percent-
ages as appropriate. Unpaired student t tests were used to
see statistical signiﬁcance difference for interval variables and
chi-square tests or Fisher’s exact tests were performed for cat-
egorical variables between the groups. P value 0.05 (two tailed)
was considered statistically signiﬁcant level. SPSS 19.0 Statisti-
cal Package was used for the analysis.Highest level of sensory block
T4 10 (40%) 11 (44%)
T3 11 (44%) 11 (44%)
T2 4 (16%) 3 (12%) 0.91
Data are mean ± standard deviation. DBF: (dexmedetomidine,
bupivacaine and fentanyl group), BF: (bupivacaine and fentanyl
group).
* Statistically signiﬁcant.4. Results
The demographic proﬁles of the patients in both the groups
were comparable with regard to age, weight and height. The
distribution as per ASA status was similar in both the groups
and mean duration of surgery was comparable in both the
groups (P= 0.74) (Table 1).
Table 2 shows that the time needed for the block to reach
T4, highest level of sensory block (S max), time interval
between anesthesia and onset of surgery and recovery from
motor blockade were not signiﬁcant statistically. The onset
of postoperative pain was signiﬁcantly delayed in the DBF
group (P= 0.001).
In DBF group all women did not need any supplementary
analgesic throughout the operation while in the DF group 6
patients needed supplementary fentanyl (P= 0.03) for com-
plaining intraoperative pain or discomfort (deﬁned as
VRS > 4).
The postoperative analgesic requirement was signiﬁcantly
reduced in DBF group compared to DF group (P= 0.01).
Shivering also was signiﬁcantly reduced in DBF group com-
pared to DF group (P= 0.03). Incidence of hypotension, bra-
dycardia, nausea, vomiting, dizziness and pruritus were not
signiﬁcant between the groups (Table 3). There were also no
signiﬁcant differences in neonatal outcomes in both groups.
Sedation scores were signiﬁcantly higher in DBF group
(P= 0.001) (Table 4).
5. Discussion
Our study emphasized that the addition of dexmedetomidine
1 lg/kg to a standardized CSE dosage regimen (bupivacaine
and fentanyl) achieved better intraoperative conditions;
improved analgesia and provided good sedation level, pro-longed postoperative analgesia and lower incidence of shiver-
ing than those who received only bupivacaine and fentanyl.
Epidural dexmedetomidine in dose of 1 lg/kg did not cause
signiﬁcant hemodynamic effects and did not affect neonatal
outcome. Dexmedetomidine as adjuvant to bupivacaine and
fentanyl achieved better sedation, as forty percent of the
patients had sedation in score 3 and were arousable by gentle
tactile stimulation compared to no patients in BF group. Sixty
percent of the patients remained awake but calm in BF group
compared to sixteen percent in DBF group who were equally
cooperative and calm. Overall sedation scores were statistically
more in dexmedetomidine group (DBF group).
Our data support the previous studies that used dexmede-
tomidine as additive to regional anesthetics; Salgado et al.,
in a double blind study conducted in 40 patients undergoing
hernia repair or varicose vein surgery; concluded that adding
dexmedetomidine 1 lg/kg to epidural ropivacaine increases
sensory and motor block duration and prolongs postoperative
analgesia, without causing hemodynamic instability [11].
Bajwa et al., compared dexmedetomidine 1.5 lg/kg versus
clonidine 2 lg/kg as an additive to epidural ropivacaine in
patients scheduled for vaginal hysterectomy. They observed
that dexmedetomidine is a better adjuvant than clonidine in
terms of intraoperative and postoperative analgesia, patient’s
satisfaction and cardio-respiratory effects [31].
El-Hennawy et al., compared dexmedetomidine versus
clonidine as additive to caudal bupivacaine in children aged
Table 3 Incidence of side effects.
DBF (No-25) BF (No-25) P value
Incidence of side eﬀects
Hypotension 4 (16%) 3 (12%) 0.68
Bradycardia 1 (4%) 0 0.32
Nausea and vomiting 1 (4%) 2 (8%) 0.55
Intraoperative pain or
discomfort
0 6 (24%) 0.03*
Postoperative pain 3 (12%) 12 (48%) 0.01*
Shivering 1 (4%) 8 (32%) 0.03*
Pruritus 1(4%) 1 (4%) 1.00
Dizziness 0 0 –
Respiratory depression 0 0 –
Supplementary fentanyl
Intraoperative requirement 0 6 (24%) 0.03*
Postoperative requirement 3 (12%) 12 (48%) 0.01*
Data are number (%). DBF: (dexmedetomidine, bupivacaine and
fentanyl group), BF: (bupivacaine and fentanyl group).
* Statistically signiﬁcant.
Table 4 Comparison of intra-operative sedation scores in
patients of group DBF and group BF.
Sedation scores during surgery DBF (No-25) BF (No-25) P value
1 4 (16%) 15 (60%)
2 11 (44%) 10 (40%)
3 10 (40%) 0 0.001*
Data are number (%). DBF: (dexmedetomidine, bupivacaine and
fentanyl group), BF: (bupivacaine and fentanyl group).
* Statistically signiﬁcant.
356 S.E. Hanoura et al.6 months–6 years undergoing lower abdominal surgeries and
concluded that both drugs signiﬁcantly improve postoperative
analgesia [10].
Antishivering mechanism of dexmedetomidine had been
studied but not extensively. In the present study, we obtained
satisfactory results in the prevention of shivering in patients
who were administered with dexmedetomidine as only one
patient out of total 25 suffered an episode of shivering. The
a-2 receptor agonists are known to prevent shivering to a mod-
erate extent without any associated respiratory depression as
with other antishivering drugs such as meperidine, dexmede-
tomidine reduces shivering by lowering vasoconstriction and
shivering thresholds [32].
Kanazi et al., investigated the effect of adding a small dose
of 3 lg of intrathecal dexmedetomidine to 12 mg bupivacaine
and found a signiﬁcant prolongation of sensory and motor
block as compared to bupivacaine alone [33]. In dissimilarity
to our study, we failed to demonstrate a statistically signiﬁcant
change in sensory and motor block time.
On the other hand Konaki et al., demonstrated that 10 mcg
of dexmedetomidine HCl produces moderate to severe demye-
lination of spinal cord white matter in rabbits following epidu-
ral administration. They postulate that the low pH of 4.5–7.0
of dexmedetomidine is responsible for the injury to the myelin
sheath [34]. However clonidine with similar pH (5–7) does not
exert neurotoxic side effects [35–37].
To our knowledge, there is no previous study on using dex-
medetomidine during cesarean section had not been addressedapart from only individual case reports; Neumann et al., used
dexmedetomidine to facilitate awake ﬁberoptic endotracheal
intubation for patient with spinal muscular atrophy 10 min
before cesarean delivery and found no serious neonatal effects
were detected [27]. Similarly, Palanisamy et al., used intrave-
nous dexmedetomidine successfully as an adjunct to opioid-
based PCAand general anesthesia for cesarean delivery in a par-
turient with a tethered spinal cord, and they achieved favorable
maternal and neonatal outcome [28]. Also, others used intrave-
nous dexmedetomidine infusion for labor analgesia in patient
with preeclampsia without signiﬁcant neonatal side effects [29].
The limitations of this study were the relatively small num-
ber of patients included and lack of follow up of patients till
time of discharge from hospital. The strengths of this study
were performance of the surgical procedure by two consultants
with the same experiences in a single center and postoperative
data collected by single blinded investigator.6. Conclusion
Addition of dexmedetomidine 1 lg/kg to an epidural bupiva-
caine/fentanyl combination in patients undergoing elective
cesarean section using the CSE technique improves the
intraoperative conditions; provides good sedation level and
improves the quality of postoperative analgesia without
signiﬁcant maternal or neonatal side effects.
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